QA: Oncternal Therapeutics Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001260990_2015_Oncternal_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001260990, Oncternal Therapeutics Inc

  xvar xval
0 AssetsCurrent 50,151,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 29,000
3 remainder_Assets 471,000
4 LiabilitiesCurrent 32,792,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,877,373
9 ResearchAndDevelopmentExpense 17,524,061
10 remainder_Expenses 7,912,772
11 remainder_Revenues 0
12 remainder_NetIncome 261,780
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 50,651,000
1 Liabilities 32,792,000
2 Expenses 35,314,206
3 Revenues 0
4 StockholdersEquity 17,859,000
5 NetIncome -35,052,426
6 ComprehensiveNetIncome -35,052,426
7 BaseVar 59,509,493
8 EconomicCapitalRatiobeforeLimitedLiability 0.0930
9 EconomicCapitalRatio 1.50

Edgar->Model Mapping

Feature Distribution

Change over Time